SEC Filing | Abbott Laboratories

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Warmuth Michael J

(Last)

(First)

(Middle)

100 ABBOTT PARK ROAD

(Street)

ABBOTT PARK

60064-6400

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/15/2008

3. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Senior Vice President

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common shares without par value	34,979	D
Common shares without par value	23⁽¹⁾	I	Profit Sharing Trust
Common shares without par value	72⁽²⁾	I	Held by spouse

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Option (right to buy)⁽³⁾	02/12/2001	02/11/2009	Common shares	844	42.5	D
Option (right to buy)⁽³⁾	02/12/2002	02/11/2009	Common shares	2,353	42.5	D
Option (right to buy)⁽³⁾	02/11/2003	02/10/2010	Common shares	3,065	32.61	D
Option (right to buy)⁽³⁾	02/09/2002	02/08/2011	Common shares	3,724	45.45	D
Option (right to buy)⁽³⁾	02/09/2003	02/08/2011	Common shares	3,723	45.45	D
Option (right to buy)⁽³⁾	02/09/2004	02/08/2011	Common shares	1,525	45.45	D
Option (right to buy)⁽³⁾	02/09/2003	02/08/2011	Common shares	1	45.45	D
Option (right to buy)⁽³⁾	02/09/2004	02/08/2011	Common shares	2,199	45.45	D
Option (right to buy)⁽³⁾	02/15/2003	02/14/2012	Common shares	4,788	53.63	D
Option (right to buy)⁽³⁾	02/15/2004	02/14/2012	Common shares	4,788	53.63	D
Option (right to buy)⁽³⁾	02/15/2005	02/14/2012	Common shares	2,897	53.63	D
Option (right to buy)⁽³⁾	02/15/2005	02/14/2012	Common shares	1,890	53.63	D
Option (right to buy)⁽³⁾	02/14/2005	02/13/2013	Common shares	2,532	33.23	D
Option (right to buy)⁽³⁾	02/14/2006	02/13/2013	Common shares	3,229	33.23	D
Option (right to buy)⁽³⁾	02/14/2004	02/13/2013	Common shares	1	33.23	D
Option (right to buy)⁽³⁾	02/14/2006	02/13/2013	Common shares	3,049	33.23	D
Option (right to buy)⁽³⁾	02/20/2005	02/19/2014	Common shares	5,285	41.03	D
Option (right to buy)⁽³⁾	02/20/2006	02/19/2014	Common shares	5,284	41.03	D
Option (right to buy)⁽³⁾	02/20/2007	02/19/2014	Common shares	2,830	41.03	D
Option (right to buy)⁽³⁾	02/20/2007	02/19/2014	Common shares	2,454	41.03	D
Option (right to buy)⁽⁴⁾	02/18/2006	02/17/2015	Common shares	4,499	46.34	D
Option (right to buy)⁽⁴⁾	02/18/2007	02/17/2015	Common shares	4,500	46.34	D
Option (right to buy)⁽⁴⁾	02/18/2008	02/17/2015	Common shares	2,343	46.34	D
Option (right to buy)⁽⁴⁾	02/18/2006	02/17/2015	Common shares	1	46.34	D
Option (right to buy)⁽⁴⁾	02/18/2008	02/17/2015	Common shares	2,157	46.34	D
Option (right to buy)⁽⁴⁾	02/17/2007	02/16/2016	Common shares	3,134	44.16	D
Option (right to buy)⁽⁴⁾	02/17/2008	02/16/2016	Common shares	3,133	44.16	D
Option (right to buy)⁽⁴⁾	02/17/2009	02/16/2016	Common shares	3,133	44.16	D
Option (right to buy)⁽⁴⁾	02/16/2008	02/15/2017	Common shares	8,934	52.54	D
Option (right to buy)⁽⁴⁾	02/16/2009	02/15/2017	Common shares	8,933	52.54	D

Explanation of Responses:

1. Balance in the Abbott Laboratories Stock Retirement Trust as of December 19, 2008.

2. The reporting person disclaims beneficial ownership of all securities held by his spouse.

3. Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

4. Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

Form 1 of 2 DerivativeTable

	John A. Berry, by power of attorney for Michael J. Warmuth	12/23/2008
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.